Annual Current Assets
$127.71 M
+$79.31 M+163.90%
December 31, 2023
Summary
- As of February 7, 2025, CTNM annual total current assets is $127.71 million, with the most recent change of +$79.31 million (+163.90%) on December 31, 2023.
- During the last 3 years, CTNM annual current assets has risen by +$57.93 million (+83.01%).
- CTNM annual current assets is now at all-time high.
Performance
CTNM Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Assets
$215.14 M
-$5.18 M-2.35%
September 30, 2024
Summary
- As of February 7, 2025, CTNM quarterly total current assets is $215.14 million, with the most recent change of -$5.18 million (-2.35%) on September 30, 2024.
- Over the past year, CTNM quarterly current assets has increased by +$87.44 million (+68.47%).
- CTNM quarterly current assets is now -2.35% below its all-time high of $220.32 million, reached on June 30, 2024.
Performance
CTNM Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Assets Formula
Current Assets = Cash and Equivalents + Accounts Receivable + Inventory + Prepaid Expenses + Marketable Securities + Other Current Assets
CTNM Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +163.9% | +68.5% |
| 3 y3 years | +83.0% | +344.6% |
| 5 y5 years | +83.0% | +344.6% |
CTNM Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +163.9% | -2.4% | +344.6% |
| 5 y | 5-year | at high | +163.9% | -2.4% | +344.6% |
| alltime | all time | at high | +163.9% | -2.4% | +344.6% |
Contineum Therapeutics Class A Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $215.14 M(-2.3%) |
| Jun 2024 | - | $220.32 M(+84.0%) |
| Mar 2024 | - | $119.71 M(-6.3%) |
| Dec 2023 | $2.68 M | $127.71 M(-7.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $137.53 M(+184.2%) |
| Dec 2022 | $2.24 M(+203.7%) | - |
| Dec 2022 | - | $48.39 M |
| Dec 2021 | $739.00 K | - |
FAQ
- What is Contineum Therapeutics Class A annual total current assets?
- What is the all time high annual current assets for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A annual current assets year-on-year change?
- What is Contineum Therapeutics Class A quarterly total current assets?
- What is the all time high quarterly current assets for Contineum Therapeutics Class A?
- What is Contineum Therapeutics Class A quarterly current assets year-on-year change?
What is Contineum Therapeutics Class A annual total current assets?
The current annual current assets of CTNM is $127.71 M
What is the all time high annual current assets for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high annual total current assets is $127.71 M
What is Contineum Therapeutics Class A annual current assets year-on-year change?
Over the past year, CTNM annual total current assets has changed by +$79.31 M (+163.90%)
What is Contineum Therapeutics Class A quarterly total current assets?
The current quarterly current assets of CTNM is $215.14 M
What is the all time high quarterly current assets for Contineum Therapeutics Class A?
Contineum Therapeutics Class A all-time high quarterly total current assets is $220.32 M
What is Contineum Therapeutics Class A quarterly current assets year-on-year change?
Over the past year, CTNM quarterly total current assets has changed by +$87.44 M (+68.47%)